FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine, namely an adhesive preparation for percutaneous introduction of 2-(4-ethyl-1-piperazinyl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydrocyclooctate[b]pyridine (compound A). The preparation contains an adhesive layer formed on one base surface wherein the adhesive layer contains (1) the compound A or its physiologically acceptable salt formed by salt addition, and (2) an acryl adhesive, or (1) the compound A or its physiologically acceptable salt formed by salt addition, (2) the acryl adhesive and (3) a permeability enhancing agent.
EFFECT: preparation inhibits metabolite generation and continuously maintains the blood drug concentration.
19 cl, 7 tbl, 1 dwg, 63 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTICANCER VACCINE COMPOSITION CONTAINING PEPTIDE WT1 FOR TRANSDERMAL ADMINISTRATION | 2014 |
|
RU2685933C2 |
| ANTICANCER VACCINE COMPOSITION CONTAINING WT1 PEPTIDE FOR TRANSDERMAL ADMINISTRATION | 2014 |
|
RU2687144C2 |
| ANTI-CANCER VACCINE PREPARATION CONTAINING PEPTIDE WT1 IN THE FORM OF A TRANSDERMAL INTRODUCTION TAPE | 2014 |
|
RU2697443C2 |
| NICOTINE TRANSDERMAL DELIVERY SYSTEM | 2006 |
|
RU2400216C2 |
| METHOD FOR MAKING PREPARATION FOR TRANSDERMAL NICOTINE INTRODUCTION | 2006 |
|
RU2403018C2 |
| PREPARATION FOR TRANSDERMAL NICOTINE INTRODUCTION AND METHOD FOR MAKING THEREOF | 2006 |
|
RU2407516C2 |
| SOLID PHARMACEUTICAL COMPOSITION CONTAINING 1-(3-(2-(1-BENZOTHIOPHENE-5-YL)ETOXY)PROPYL)AZETIDINE-3-OL OR ITS SALT | 2013 |
|
RU2625767C2 |
| ADHESIVE PLASTER | 2009 |
|
RU2474418C2 |
| TAPE-APPLIED PHENTHANYL-CONTAINING PREPARATION FOR PERCUTANEOUS USAGE | 1997 |
|
RU2194496C2 |
| ANTITHROMBOGENOUS MATERIAL | 2016 |
|
RU2675107C1 |
